TNFRSF9 and ovarian carcinoma: showed directly that ovarian cancer TSTs existed exclusively in the PD-1+CD137+CD8+ T cell subpopulation rather than the PD-1+CD8+ T cells or PD-1−CD137+CD8+ T cell subpopulation.